Pro Share Advisors LLC Myriad Genetics Inc Transaction History
Pro Share Advisors LLC
- $42.5 Billion
- Q4 2024
A detailed history of Pro Share Advisors LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 26,982 shares of MYGN stock, worth $298,420. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,982
Previous 24,049
12.2%
Holding current value
$298,420
Previous $658,000
43.92%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding MYGN
# of Institutions
227Shares Held
92MCall Options Held
297KPut Options Held
20.7K-
Black Rock Inc. New York, NY15.2MShares$168 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$117 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$66.4 Million0.02% of portfolio
-
State Street Corp Boston, MA5.53MShares$61.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.35MShares$48.1 Million0.03% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $892M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...